e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) December 22, 2008
NOVAVAX, INC.
(Exact name of Registrant as specified in its charter)
         
Delaware
(State or other jurisdiction of incorporation or
organization)
  0-26770
(Commission File Number)
  22-2816046
(I.R.S. Employer Identification No.)
     
9920 Belward Campus Drive    
Rockville, Maryland   20850
(Address of principal executive offices)   (Zip Code)
     
Registrant’s telephone number, including area code:  (240) 268-2000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On December 22, 2008, Len Stigliano announced his intent to resign as Vice President, Chief Financial Officer and Treasurer of Novavax, Inc. (the “Company”), effective as to the close of business on January 28, 2009. The Company has retained an executive search firm to recruit a new Chief Financial Officer. Mr. Stigliano intends to pursue employment opportunities within the Philadelphia area where he and his family reside.

2


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
    Novavax, Inc.
(Registrant)
 
       
December 30, 2008
  By:   /s/Len Stigliano
 
       
 
  Name:   Len Stigliano
 
  Title:   Vice President, Chief Executive Officer
 
      and Treasurer

3